-20℃ 3 years powder
-80℃ 2 years in solvent
Elagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | 48.00 | |
5 mg | In stock | 68.00 | |
10 mg | In stock | 104.00 | |
25 mg | In stock | 227.00 | |
50 mg | In stock | 410.00 | |
100 mg | In stock | 590.00 | |
1 mL * 10 mM (in DMSO) | In stock | 95.00 |
Description | Elagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM, respectively). |
Targets&IC50 | GnRHR :ic50 3.7 nM, |
In vivo | Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain[1] |
Synonyms | NBI-56418 sodium , NBI-56418 sodium |
Purity | 99.93% |
Molecular Weight | 653.57 |
Formula | C32H29F5N3NaO5 |
CAS No. | 832720-36-2 |
-20℃ 3 years powder
-80℃ 2 years in solvent
DMSO: 50 mg/mL (76.50 mM)
H2O: 50 mg/mL (76.50 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.